期刊文献+

正确看待多学科综合治疗在头颈部鳞状细胞癌治疗中的地位和作用 被引量:7

A proper view of the position and roles of multidisciplinary treatment of head neck squamous cell carcinomas
原文传递
导出
摘要 在世界范围内,头颈癌发病占全身恶性肿瘤发病的第6位,并有逐年增高的趋势.从临床病理学研究的角度看,头颈癌最常见的病理类型为鳞状细胞癌(简称鳞癌),约占头颈癌的90%以上[1].多年来,头颈鳞癌的治疗方法一直以手术治疗为主,但单纯手术控制中晚期头颈鳞癌的效果远不够理想.尽管放化疗等手段和技术在不断引入,但头颈鳞癌患者的总体5年生存率在近些年没有得到显著提高.
作者 李晓明
出处 《中华耳鼻咽喉头颈外科杂志》 CAS CSCD 北大核心 2016年第7期481-484,共4页 Chinese Journal of Otorhinolaryngology Head and Neck Surgery
  • 相关文献

参考文献15

  • 1Lang J, Gao L, Guo Y, et al. Comprehensive treatment ofsquamous cell cancer of head and neck : Chinese expert consensus2013[ J]. Future Oncol, 2014, 10(9) : 1635-1648.
  • 2Friedland PL, Bozic B, Dewar J, et al. Impact ofmultidisciplinary team management in head and neck cancerpatients[J]. Br J Cancer,2011,104(8); 1246-1248.
  • 3Bradley PJ. Multidisciplinary clinical approach to the managementof head and neck cancer [ J ]. Eur Arch Otorhinolaryngol, 2012,269(12) ; 2451-2454.
  • 4Prades J, Remue E, van Hoof E, et al. Is it worth reorganisingcancer services on the basis of multidisciplinary teams (MDTs) ? Asystematic review of the objectives and organisation of MDTs andtheir impact on patient outcomes [ J ]. Health Policy, 2015,119(4). 464-474.
  • 5赵晓莹,郭晔,朱永学,王宇,朱国培,胡超苏,嵇庆海.尼妥珠单抗联合顺铂和氟尿嘧啶方案诱导化疗治疗可切除的头颈部鳞癌初步临床分析[J].中华耳鼻咽喉头颈外科杂志,2012,47(7):536-539. 被引量:15
  • 6Perri F,Muto P, Aversa C, et al. Integrated therapeuticapproaches in head and neck cancer: the importance ofmultidisciplinary team management [ J ]. Anticancer Agents MedChem. 2013, 13(6) : 834-843.
  • 7Fujii M. Multidisciplinary approach for the treatment of head andneck cancer [ J ]. Int J Clin Oncol, 2014, 19 (2): 209-210.
  • 8Bernier J, Cooper JS, Pajak TF, et al. Defining risk levels inlocally advanced head and neck cancers : a comparative analysis ofconcurrent postoperative radiation plus chemotherapy trials of theEORTC (#22931) and RTOG (#9501) [J]. Head Neck, 2005,27(10) : 843-850.
  • 9邸斌,李晓明,张建军,刘爽,宋琦,陶振峰,范才.头颈部鳞状细胞癌术后放疗控制颈部淋巴结转移的临床病理学影响因素分析[J].中华耳鼻咽喉头颈外科杂志,2016,51(7):485-490. 被引量:11
  • 10张欣欣,王嘉陵,武文明,马林,刘明波,赵飞帆,黄德亮.非手术综合治疗保留中晚期下咽癌患者喉器官的临床研究[J].中华耳鼻咽喉头颈外科杂志,2014,49(7):558-563. 被引量:17

二级参考文献91

  • 1杨学宁,吴一龙.实体瘤治疗疗效评价标准——RECIST[J].循证医学,2004,4(2):85-90. 被引量:1480
  • 2沈松杰,郭俊超,廖泉,赵玉沛.MAPK信号转导通路在肿瘤化疗耐药中的作用[J].国外医学(肿瘤学分册),2005,32(8):579-582. 被引量:9
  • 3王强,董频,王文栋,徐成志,王国良.喉癌中p14ARF基因缺失与mdm2、c-jun蛋白的表达[J].中国耳鼻咽喉头颈外科,2006,13(2):74-76. 被引量:1
  • 4Lefebvre JL,Chevalier D,Luboinski B,et al.Larynx preservation in pyriform sinus cancer:preliminary results of a European Organization for Research and Treatment of Cancer phase Ⅲ trial.EORTC Head and Neck Cancer Cooperative Group[J].J Natl Cancer Inst,1996,88(13):890-899.
  • 5Rades D,Schroeder U,Bajrovic A,et al.Radiochemotherapy versus surgery plus radio(chemo) therapy for stage T3/T4 larynx and hypopharynx cancer-results of a matched-pair analysis[J].Eur J Cancer,2011,47(18):2729-2734.
  • 6Okamoto M,Takahashi H,Yao K,et al.Clinical impact of using chemoradiotherapy as a primary treatment for hypopharyngeal cancer[J].Acta Otolaryngol Suppl,2002,(547):11-14.
  • 7Soo KC,Tan EH,Wee J,et al.Surgery and adjuvant radiotherapy vs concurrent chemoradiotherapy in stage Ⅲ/Ⅳ nonmetastatic squamous cell head and neck cancer:a randomised comparison[J].Br J Cancer,2005,93(3):279-286.
  • 8Paximadis P,Yoo G,Lin HS,et al.Concurrent chemoradiotherapy improves survival in patients with hypopharyngeal cancer[J].Int J Radiat Oncol Biol Phys,2012,82(4):1515-1521.
  • 9Bonner JA,Harari PM,Giralt J,et al.Radiotherapy plus cetiximab for squamous cell carcinoma of the head and neck[J].N Engl J Med,2006,354(6):567-578.
  • 10Liu WS,Hsin CH,Chou YH,et al.Long-term results of intensity-modulated radiotherapy concomitant with chemotherapy for hypopharyngeal carcinoma aimed at laryngeal preservation[J].BMC Cancer,2010,10:102-112.

共引文献53

同被引文献51

引证文献7

二级引证文献17

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部